What is Vertex Pharmaceuticals's oci attributable to parent?

Vertex Pharmaceuticals (VRTX) reported oci attributable to parent of $36.60M in Q3 2025.

How has Vertex Pharmaceuticals's oci attributable to parent changed year-over-year?

Vertex Pharmaceuticals's oci attributable to parent increased by 481.0% year-over-year, from $6.30M to $36.60M.

What does oci attributable to parent mean?

The share of total comprehensive income belonging to the parent company's owners.

Discontinued — last reported Q4 '18

OCI Attributable to Parent

Vertex Pharmaceuticals OCI Attributable to Parent increased by 121.6% to $36.60M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 481.0%, from $6.30M to $36.60M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement

SectionOther

CategoryOther

SignalHigher is better

VolatilityVolatile

First reportedQ1 2013

Last reportedQ4 2018

How to read this metric

Reflects the net impact of external financial factors on the parent company's book value.

Detailed definition

The portion of total other comprehensive income that belongs to the shareholders of the parent company, excluding any am...

Peer comparison

Standard reporting requirement for consolidated entities; comparable to 'comprehensive income attributable to parent' at peer firms.

Metric ID: is_wmt_oci_attributable_to_parent

Historical Data

8 periods

	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q2 '24	Q3 '24	Q2 '25	Q3 '25
Value	-$3.78M	-$3.78M	-$3.78M	-$3.78M	$5.20M	$6.30M	-$169.20M	$36.60M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+237.7%	+21.2%	<-999%	+121.6%
YoY Change	—	—	—	—	+237.7%	+266.9%	<-999%	+481.0%

Range-$169.20M – $36.60M

CAGR+266.2%

Avg YoY Growth-592.1%

Median YoY Growth+252.3%